Logo image of CBIO

CRESCENT BIOPHARMA INC (CBIO) Stock Analyst Ratings

NASDAQ:CBIO - KYG2545C1042 - Common Stock

15.06 USD
+0.66 (+4.58%)
Last: 8/22/2025, 8:00:02 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CBIO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 26.01. This target is 72.71% above the current price.
CBIO was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CBIO.
In the previous month the buy percentage consensus was at a similar level.
CBIO was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

CBIO Historical Analyst RatingsCBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -96 -87 -78 -69 -60 -51 -42 -33 -24 -15 -6 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 15.0622.2226.5226.0129.40 - 47.54% 76.10% 72.71% 95.22%

Related screens

CBIO Current Analyst RatingCBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-08-11 HC Wainwright & Co. Initiate Buy
2025-07-14 Wedbush Initiate Outperform
2025-06-25 Stifel Initiate Buy
2025-06-18 LifeSci Capital Initiate Outperform
2021-11-15 Raymond James Downgrade Outperform -> Market Perform
2021-08-06 Raymond James Maintains Outperform
2021-04-29 Raymond James Maintains Outperform
2021-02-10 Piper Sandler Initiate Overweight